EntryPoint Capital’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
EntryPoint Capital's RMD Position: Q2 2026 in Review
EntryPoint Capital increased its ResMed (RMD) stake by 155% in Q2 2026, buying an estimated $941K and bringing the position to 7,464 shares worth $1.45M. The position accounts for 0.35% of the portfolio, ranked #28.
EntryPoint Capital first reported a position in RMD in Q4 2023 and has held it in 7 quarters since. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- EntryPoint Capital held 7,464 shares of ResMed worth $1.45M as of Q2 2026.
- EntryPoint Capital bought 4,538 ResMed shares in Q2 2026, an estimated $941K.
- ResMed made up 0.35% of EntryPoint Capital's portfolio in Q2 2026, its #28 holding.
- EntryPoint Capital first reported a position in ResMed in Q4 2023 and has held it in 7 quarters since.
- 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on EntryPoint Capital's 13F filing for Q2 2026, filed 13 Aug 2026.